Apex Capital Management - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 102 filers reported holding ANI PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Apex Capital Management ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$6,593,000
-10.3%
195,877
+20.3%
0.14%
-11.6%
Q4 2015$7,346,000
+23.3%
162,798
+7.9%
0.16%
+21.5%
Q3 2015$5,960,000
-30.0%
150,845
+9.9%
0.14%
-25.8%
Q2 2015$8,520,000
+12.7%
137,308
+13.6%
0.18%
+2.2%
Q1 2015$7,562,000
+46.2%
120,899
+31.9%
0.18%
+29.0%
Q4 2014$5,171,00091,6920.14%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders